Researchers at the University of Pittsburgh are making strides against Pancreatic Cancer with the help of an experimental vaccine.
The vaccine is made up of a patient's own cells and a protein that is associated with the disease. It is designed to trigger a patient's immune system to fight the cancer.
In this first study, 12 patients got the vaccine, two shots three months apart with a booster shot six months later.
Now, three years later, four of those patients have no evidence of the disease. Researchers say since Pancreatic Cancer is aggressive and so diffucult to treat that this study is very promising.
This study is led by researchers at the University of Pittsburgh School of Medicine and presented at the AACR conference in Los Angeles.
For more info call Clare Collins 412-647-3555.